The nuclear physics group at the University of Illinois Urbana-Champaign is look...
How can Marvel movie character Ant-Man produce such strong energy out of his sma...
A stop smoking mobile app that senses where and when you might be triggered to l...
PITTSBURGH, April 13, 2023 – In a paper published today in Molecular Psychiatry,...
After filing for bankruptcy last December, Clovis Oncology found a tentative buy...
Pharmaceutical company AstraZeneca has revealed that a Phase 3 clinical trial of...
After the 3rd U.S. Circuit Court of Appeals in Philadelphia called out Johnson &...
C2N Diagnostics introduced its second-generation liquid biopsy technology to det...
Interim analysis of the Neotorch trial revealed that the combo therapy could not...
The FDA approval was based on the data obtained from an open-label, pivotal Phas...
With lower screening rates, many of these cancers will probably be detected at a...
Novo Nordisk and Aspect enter a multimillion dollar partnership to produce pancr...
Foundation Medicine’s tissue-based test will be a companion diagnostic to BMS’s ...
Panbela will lead on the design of the global trial protocol.
The collaboration will leverage LyGenesis’s allogeneic cell therapy platform and...
The collaboration will advance the development of Xenetic’s systemic DNase progr...
